Myria ventures into the uncharted chemical space of natural product-inspired molecules to retrieve novel drug candidates. The GEMMS Platform Genetically Engineered Modular Molecule Scaffolds Design and biological production of therapeutic compounds far beyond what nature's evolution has provided. Unlocking new chemical space aiming at challenging disease targets. Engineering cells to produce & test millions of novel molecules in a single week to generate and optimise targeted biopharmaceuticals. Myria unlocks nature’s molecular toolkit with data-driven design. New chemical matter, built with biology.
